Maintenance therapy with anlotinib after induction therapy with platinum-based chemotherapy for advanced non-small-cell lung cancer: A pooled analysis of 2 single-arm trials.

Yiqian LiuLiyun MiaoXiao ChenXiaoli ZhuYan LiJingdong HePing ChenShengbin DaiZiling LiuKewei MaNanya WangYuguang ZhaoNaifei ChenWei SongRilan BaiJiu-Wei CuiYongqian Shu

Published in: Medicine (2024)

Anlotinib might offer a new option for maintenance treatment in patients with locally advanced or metastatic NSCLC without known sensitive mutations after standard first-line platinum-based chemotherapy.

Keyphrases

advanced non small cell lung cancer
locally advanced
squamous cell carcinoma
rectal cancer
small cell lung cancer
neoadjuvant chemotherapy
epidermal growth factor receptor
radiation therapy
phase ii study
randomized controlled trial
mesenchymal stem cells
combination therapy